Why Implement an MES in Pharmaceutical Manufacturing?
Manufacturing Execution Systems (MES) can improve productivity, consistency, and data integrity across pharmaceutical operations. However, many MES projects fail because organisations focus on software before process improvement. To minimise risk and achieve measurable return on investment, manufacturers must begin with clear process objectives and defined validation requirements.
Start with Process Improvement, Not Software
Manufacturing Execution Systems (MES) can improve productivity, consistency, and data integrity across pharmaceutical operations. However, many MES projects fail because organisations focus on software before process improvement. To minimise risk and achieve measurable return on investment, manufacturers must begin with clear process objectives and defined validation requirements.Improving Efficiency and Reducing Labour
An MES reduces labour by eliminating manual checks, paper records, and duplicated tasks. When processes are tightly controlled by the system and electronic batch records update automatically, second checking becomes unnecessary, data entry is reduced, label generation is automated, and stock consumption information feeds directly into the ERP system. As a result, operators spend less time completing paperwork and more time performing controlled production activities.
Improving Collaboration and Communication
An MES provides a shared platform for real-time production data. Departments gain access to consistent, up-to-date information, which reduces miscommunication and conflicting records. In addition, cross-functional teams can identify, track, and manage quality issues from root cause analysis through implementation of corrective actions. By centralising data, organisations improve coordination, optimise workflows, and make more informed decisions.Reducing the Cost of Errors
Human error cannot be eliminated, but its operational and financial impact can be reduced. With Ci-DMS, deviations are identified at the point of occurrence, allowing the process to stop before costs escalate. Furthermore, electronic records provide clear traceability, which simplifies investigations and reduces the time required to resolve issues. This approach lowers batch rejection rates, minimises investigation costs, and reduces compliance risk.
Reducing Material Waste
Waste reduction represents a measurable and defensible source of return on investment. Across multiple healthcare manufacturers, Ci-DMS has supported reductions in ingredient waste. Even moderate reductions in active ingredient loss can generate substantial financial benefit, particularly in high-value manufacturing environments.Ensuring Regulatory Compliance and Data Integrity
In regulated pharmaceutical manufacturing, compliance and data integrity are fundamental. An MES provides controlled electronic batch records, secure electronic signatures, centralised audit trails, and structured data governance. This strengthens GMP compliance, reduces documentation risk, and improves inspection readiness across manufacturing operations.
Project Implementation Considerations
MES projects often fail when organisations underestimate change management requirements. Common causes include lack of executive sponsorship, limited user involvement, poorly defined requirements, and unrealistic expectations. To reduce implementation risk, organisations must identify specific risk factors early, assess their impact, and define clear mitigation strategies. Structured governance and clear stakeholder communication remain essential throughout the project lifecycle.Specific figures
To enable your organisation to make an informed decision about MES and to prioritise it against other investments, we have developed a methodology and structure for creating a detailed business case. This cost-benefit analysis is based on a model of healthcare manufacturing but uses your processes and costs to provide realistic figures for return on investment.
White Paper: Benefits of a Computerised Dispensary
Download our white paper to learn how an MES supports first-time-right production and improved compliance in pharmaceutical manufacturing.En savoir plus
Poursuivez vos recherches
Download the Ci-DMS MES brochure
Learn more about our Ci-DMS MES — our powerful, versatile, and modular software for paperless manufacturing that helps you tackle even the most exacting and demanding production requirements.
Download10 Ways Checkweighers Save Pharmaceutical Manufacturers Money
Delivering consistent quality products is essential to protect your brand and your bottom line. A..
Contacter CI PrecisionAutomated Weight Sorting for Pharmaceutical Quality Control | Harwell Dosimeters
When Harwell Dosimeters wanted to control the manufacturing quality of their Alanine Pellets they chose CI Precision’s weight sorters to accurately weigh each pellet.
Contacter CI PrecisionHow you can meet us
Request a meeting, or find us at an exhibition
Request a meetingUpcoming exhibitions